JSI Research & Training Institute, Inc. has partnered with the Sabin Vaccine Institute and Dalberg to create the COVID-19 Vaccine Equity Project. This collaboration will support low- and middle-income country immunization professionals in leading the equitable delivery of COVID-19 vaccines through their national immunization programs. It complements the approach outlined in the COVAX Facility, the vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A)—led by the World Health Organization (WHO); Gavi, the Vaccine Alliance (Gavi); and the Coalition for Epidemic Preparedness Innovations (CEPI).
The Skoll Foundation is generously supporting the creation of the COVID-19 Vaccine Equity Project through start-up funding of $1 million to begin assistance with four countries. Following a successful pilot, the partners hope to secure additional funding to scale the project to more than 40 countries starting in 2021.